Notably, during anti-TB therapy, both drug-sensitive and drug-resistant TB patients exhibit a decrease in TNFR1 and TNFR2 expression on CD4+ T cells; however, only individuals with drug-resistant TB maintain elevated TNF and TNFR2 transcript levels, suggesting persistent immune activation despite treatment [318]. The gene discussed is TNFRSF1A; the disease is tuberculosis.